Edwards Lifesciences (NYSE: EW) files Form 144 for proposed common sale

Rhea-AI Filing Summary

Edwards Lifesciences submitted a Form 144 disclosing a proposed sale of common stock through Charles Schwab & Co. The filing lists transaction dates 02/22/2025 and 06/28/2024, and shows a filing/processing date of 05/29/2026. The entry references restricted‑stock lapse and an ESPP disposition.

Insights

Securities Compliance Attorney

Form 144 notifies the market of a planned sale under Rule 144; it is an administrative disclosure.

The filing lists a broker-dealer (Charles Schwab & Co.) and transaction types including Restricted Stock Lapse and an ESPP disposition. Dates shown are 02/22/2025, 06/28/2024, and filing date 05/29/2026.

Execution, timing, and proceeds treatment are governed by Rule 144 conditions; final sale amounts and cash‑flow recipients depend on subsequent transactions and are not specified in the excerpt.

Key Figures

Filing date: 05/29/2026 Transaction date (restricted stock lapse): 02/22/2025 Transaction date (ESPP): 06/28/2024 +4 more

7 metrics

Filing date 05/29/2026 Processing/filing date shown on record

Transaction date (restricted stock lapse) 02/22/2025 Listed as Restricted Stock Lapse date

Transaction date (ESPP) 06/28/2024 Listed as ESPP disposition date

Numeric entry 568 Numeric field associated with securities table

Numeric entry 48,853.00 Numeric field shown in the securities section

Numeric entry 575,800,000 Large numeric entry present in the securities section

Per‑transaction share examples 252; 316 Counts listed alongside specific transaction dates in the excerpt

Key Terms

Form 144, Restricted Stock Lapse, ESPP

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Lapse financial

"Common | 02/22/2025 | Restricted Stock Lapse"

ESPP financial

"06/28/2024 | ESPP - See Remarks"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 05/29/2026 - 04:12 PM Accepted by SEC EDGAR 05/29/2026 - 04:12 PM Learn about SEC filing dates

FAQ

What does Edwards Lifesciences' Form 144 (EW) report?

It reports a proposed sale of Edwards Lifesciences common stock through Charles Schwab. The filing lists transaction types including restricted stock lapse and ESPP dispositions with dates 02/22/2025 and 06/28/2024.

Who is the broker‑dealer listed on the Edwards Lifesciences Form 144?

The broker‑dealer shown is Charles Schwab & Co., Inc.. The filing entry includes the broker address and exchange designation NYSE with a processing date of 05/29/2026.

Does the Form 144 specify the number of shares being sold for EW?

The excerpt lists numeric entries such as 568, 48853.00, and 575800000, but it does not present a clear single labeled registered offering total. The filing lists transaction records tied to specific dates instead.

What transaction types are disclosed on the filing for Edwards Lifesciences?

The filing references a Restricted Stock Lapse on 02/22/2025 and an ESPP disposition on 06/28/2024. It also notes equity compensation and cash entries in the remarks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	568	48853.00	575800000	05/29/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/22/2025	Restricted Stock Lapse	EDWARDS LIFESCIENCES CORPORATION			252	02/22/2025	Equity Compensation
Common	06/28/2024	ESPP - See Remarks	EDWARDS LIFESCIENCES CORPORATION			316	06/28/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)